Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited)

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional paid in capital
Retained earnings
Accumulated other comprehensive loss
Non- controlling interest
Shares issued, beginning of period (in shares) at Mar. 31, 2021   58,443,212        
Equity, beginning of period at Mar. 31, 2021 $ 307,673 $ 58 $ 135,261 $ 214,429 $ (40,434) $ (1,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation (in shares)   1,031,500        
Stock based compensation 2,162   2,162      
Capital contributions 1,265   1,265      
Translation difference 3,022       3,022  
Other comprehensive reserve 907       907  
Net income (loss) 55,368     55,420   (52)
Shares issued, end of period (in shares) at Jun. 30, 2021   59,474,712        
Equity, end of period at Jun. 30, 2021 370,397 $ 58 138,688 269,849 (36,505) (1,693)
Shares issued, beginning of period (in shares) at Mar. 31, 2022   59,542,212        
Equity, beginning of period at Mar. 31, 2022 546,608 $ 59 174,745 441,924 (63,125) (6,995)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation 3,698   3,698      
Acquisition of insurance companies (26,588)   (26,588)      
Capital contributions 677   677      
Translation difference 21,990       21,990  
Other comprehensive reserve 1,459       1,459  
Net income (loss) 59,072     61,066   (1,994)
Shares issued, end of period (in shares) at Jun. 30, 2022   59,542,212        
Equity, end of period at Jun. 30, 2022 $ 606,916 $ 59 $ 152,532 $ 502,990 $ (39,676) $ (8,989)